Is the "peptide craze" just a shortcut to weight loss, or the beginning of a structural shift in how we rebuild the human body? Today, we map the leap from metabolic stabilizers to cognitive enhancers like Semax and Cerebrolysin, and reveal the hidden systems turning these molecules into a global economic powerhouse.
Key Takeaways:
- The $21B Explosion: Why the biohacking market is growing at 15.4% annually, driven by a shift toward "productive longevity".
- Neurorestoration vs. Tuning: Understanding the difference between drugs that briefly mask symptoms and peptides that fundamentally rebuild synaptic infrastructure.
- The 2026 Regulatory Pivot: How the restoration of 14 key peptides (including BPC-157 and Selank) to FDA Category 1 status is disrupting the gray market.
- The Protocol is the Product: Inside "The Shrine" and the strategy of using supplement commerce to fund large-scale N-of-1 clinical data platforms.
- Brain Repair Toolkit: A look at Cerebrolysin’s deep research base and its role in treating everything from brain fog to post-stroke recovery.
What is Longevity Biosciences: Science, Economy & Regulations?
The ecosystem view of longevity science, wellness industry, biomedicines and everything fuzzy in between.
Definition driven, research news , first-principle grounded multi-AI agentic discussions